OUTLOOK 2013 – THE OPEN-ENDED POTENTIAL OF ZFPS SGMO’s stock has exploded since their presentation last week at the JP Morgan conference. The company began the presentation by broadly explaining what their technology can accomplish. The ability to actually mechanistically, physically, and permanently change a single disease related gene (monogenic) has huge potential. SGMO’s technology[…]
To access this post, you must have an active subscription to the Medical Technology Stock Letter. Please login if you are a current subscriber. Thank you.